BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 7986687)

  • 21. [Pseudolymphoma of the skin: ambiguous terminology: a survey among dermatologists and pathologists].
    Levy E; Godet J; Cribier B; Lipsker D
    Ann Dermatol Venereol; 2013 Feb; 140(2):105-11. PubMed ID: 23395491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic difficulties in 'non-mycotic' cutaneous lymphoproliferative diseases.
    Slater DN
    Histopathology; 1992 Sep; 21(3):203-13. PubMed ID: 1398519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. General lessons from cutaneous lymphoma.
    Slater DN
    Br J Hosp Med; 1995 Nov 1-14; 54(9):426-8. PubMed ID: 8564176
    [No Abstract]   [Full Text] [Related]  

  • 24. Reduced number of CD1a+ cells in cutaneous B-cell lymphoma.
    Schmuth M; Sidoroff A; Danner B; Topar G; Sepp NT
    Am J Clin Pathol; 2001 Jul; 116(1):72-8. PubMed ID: 11447755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary cutaneous lymphomas other than mycosis fungoides.
    Gilliam AC; Wood GS
    Semin Oncol; 1999 Jun; 26(3):290-306. PubMed ID: 10375086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug-associated lymphoma and pseudolymphoma: recognition and management.
    Albrecht J; Fine LA; Piette W
    Dermatol Clin; 2007 Apr; 25(2):233-44, vii. PubMed ID: 17430760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation, Diagnosis, and Staging of Cutaneous Lymphoma.
    Olsen EA
    Dermatol Clin; 2015 Oct; 33(4):643-54. PubMed ID: 26433839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Current approaches to diagnosing and treating primary cutaneous lymphomas on the basis of a new WHO-EORTC classification, cutaneous T-cell lymphomas].
    Belousova IE; Kazakov DV; Krivolapov IuA
    Arkh Patol; 2007; 69(5):11-7. PubMed ID: 18074813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary cutaneous B-cell lymphomas and pseudolymphomas: review of histopathological features.
    Kazakov DV; Burg G; Kempf W
    Cesk Patol; 2002 Oct; 38(4):147-54. PubMed ID: 12629860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cutaneous lymphoproliferative disorders: Back to the future.
    Willemze R
    J Cutan Pathol; 2024 Jun; 51(6):468-476. PubMed ID: 38499969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary cutaneous B-cell lymphomas. Current concepts. I.
    Santucci M; Pimpinelli N
    Haematologica; 2004 Nov; 89(11):1360-71. PubMed ID: 15531459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Synopsis of primary cutaneous lymphomas].
    Piérard GE; Hermanns-Lê T; Arrese JE; Piérard-Franchimont C
    Rev Med Liege; 1996 Dec; 51(12):754-8. PubMed ID: 9064704
    [No Abstract]   [Full Text] [Related]  

  • 33. Apoptotic and proliferating cells in cutaneous lymphoproliferative diseases.
    Kikuchi A; Nishikawa T
    Arch Dermatol; 1997 Jul; 133(7):829-33. PubMed ID: 9236520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cutaneous lymphomas. Quality Assurance Committee of the German Society of Dermatology and the Professional Organization of German Dermatologists e. V].
    Dummer R
    Hautarzt; 1998 Oct; 48 Suppl 1():S49-55. PubMed ID: 9866049
    [No Abstract]   [Full Text] [Related]  

  • 35. Primary cutaneous B-cell lymphomas: then and now.
    Kerl H; Cerroni L
    J Cutan Pathol; 2006 Feb; 33 Suppl 1():1-5. PubMed ID: 16412206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent advances in cutaneous lymphomas.
    Dummer R; Asagoe K; Cozzio A; Burg G; Doebbeling U; Golling P; Fujii K; Urosevic M
    J Dermatol Sci; 2007 Dec; 48(3):157-67. PubMed ID: 17964121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic principles and new developments in primary cutaneous B-cell lymphomas.
    Kerl H; Kodama K; Cerroni L
    J Dermatol Sci; 2004 May; 34(3):167-75. PubMed ID: 15113586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Malignant lymphoma of the skin].
    Burg G; Dommann S; Dummer R
    Ther Umsch; 1993 Dec; 50(12):828-34. PubMed ID: 8171405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The applicability and prognostic value of the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome: results on a large cohort of primary cutaneous B-cell lymphomas and comparison with the system used by the Dutch Cutaneous Lymphoma Group.
    Senff NJ; Willemze R
    Br J Dermatol; 2007 Dec; 157(6):1205-11. PubMed ID: 17941944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-dose palliative radiotherapy for cutaneous B- and T-cell lymphomas.
    Neelis KJ; Schimmel EC; Vermeer MH; Senff NJ; Willemze R; Noordijk EM
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):154-8. PubMed ID: 18834672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.